Laza Medical raises up to $160 million, led by GE HealthCare, for a robot that runs heart imaging in the cath lab

Laza Medical said on Wednesday, Nov. 4, 2026, that it raised up to $160 million in Series B structured financing led by GE HealthCare to develop its AI-powered robotic imaging system for cardiac catheterization labs.

Structural heart procedures depend on a specialist steering an imaging probe for hours, and there aren't enough of them. Laza's idea is to hand that job to a robot with AI guidance. It's still pre-approval, so this is a bet, not a product. But when the company that sells the cath-lab equipment leads the round, it's a decent hint where it expects that bet to end up.

Laza Medical raised up to $160 million in Series B structured financing. A Series B is a later venture round, the kind a company raises once it is building a real product. Structured, as Laza uses it, means the financing is set up under terms, and "up to" is the ceiling the company named. GE HealthCare led the round. Returning investors Unorthodox Ventures, PA MedTech, and AMED participated. Those lines are Laza's.

Laza is privately held. It is a portfolio company of Shifamed, a medtech incubator founded by Amr Salahieh. An incubator, here, is a shop that starts companies and stays involved as they grow. Salahieh is Laza's founder and board chairman. Those lines are Laza's.

The company is developing an AI-powered robotic imaging system for cardiovascular interventions. Cardiovascular means the heart and the blood vessels that feed it. Laza says the system is meant to simplify procedural imaging, extend the reach of specialized imaging expertise, and lay the groundwork for future robotic procedures. A cardiac catheterization lab, the cath lab, is the room where a team threads tools through blood vessels to the heart, and where someone has to keep an imaging probe aimed so the physician can see. Those lines about the system are Laza's.

Dr. Firas Zahr, head of interventional cardiology at Oregon Health Sciences University Hospital, used the software during a first-in-human clinical study last year. First-in-human means the first time it was tried in a person. That line is Laza's.

The Laza Medical System is under development. Laza says it is not approved for commercial sale in any geography. A hospital cannot order it.

Jyoti Gera, chief executive of Cardiovascular and Interventional Solutions, Advanced Imaging Solutions at GE HealthCare, said: "Integrating imaging modalities so they work seamlessly together has the potential to redefine the cath lab, enabling more efficient workflows today and paving the way for smarter, robotic procedures tomorrow." A modality is one kind of picture, such as ultrasound or X-ray. Dr. Firas Zahr said: "High-quality imaging is foundational to all successful cases." Amr Salahieh said: "The cath lab is poised for a fundamental evolution, and intelligent imaging powered by AI will play a defining role in what comes next." Those quotations are theirs.

The picture is the Laza Medical System: a white imaging cart with a raised monitor showing a 3D heart image, an angled touchscreen control panel, and a robotic arm holding a thin catheter probe. The credit is Laza Medical.

In plain terms, Laza raised up to $160 million, led by GE HealthCare, to build a robot that handles imaging during heart procedures. A physician used the software in a first-in-human study last year. The company says the system is still in development and is not approved for sale anywhere.